Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

jaffar pharmacy - tribenoside 5%, lidocaine hcl 2% - cream - 5g+2g/100g

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

jaffar pharmacy - tribenoside 400mg, lidocaine hcl 40mg - suppository

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

gulf pharmaceutical industries (julphar), united arab emirates - tribenoside,lidocaine hydrochloride - rectal ointment - 5,2 %,

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

30 g tube with applicator -

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

30 g collapsible tube -

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

julphar drug store l.l.c united arab emirates - 10's [5's blister x 2] - suppository - combination - gastrointestinal system-anal , rectal disorders

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

julphar drug store l.l.c united arab emirates - 30 g collapsible tube - cream - combination - gastrointestinal system-anal , rectal disorders

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

julphar drug store l.l.c united arab emirates - 30 g tube with applicator - ointment - combination - gastrointestinal system-anal , rectal disorders

United States - English - NLM (National Library of Medicine)

cardinal health - misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - misoprostol 200 ug - misoprostol is indicated for reducing the risk of nsaid (nonsteroidal anti-inflammatory drugs, including aspirin)–induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer. misoprostol tablet has not been shown to reduce the risk of duodenal ulcers in patients taking nsaids. misoprostol tablets should be taken for the duration of nsaid therapy. misoprostol tablets has been shown to reduce the risk of gastric ulcers in controlled studies of 3 months’ duration. it had no effect, compared to placebo, on gastrointestinal pain or discomfort associated with nsaid use. see boxed warnings . misoprostol tablets should not be taken by pregnant women to reduce the risk of ulcers induced by nonsteroidal anti-inflammatory drugs (nsaids). misoprostol tablets should not be taken by anyone with a history of all

United States - English - NLM (National Library of Medicine)

american health packaging - misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - misoprostol 100 ug - misoprostol is indicated for reducing the risk of nsaid (nonsteroidal anti-inflammatory drugs, including aspirin)–induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer. misoprostol tablet has not been shown to reduce the risk of duodenal ulcers in patients taking nsaids. misoprostol tablets should be taken for the duration of nsaid therapy. misoprostol tablets has been shown to reduce the risk of gastric ulcers in controlled studies of 3 months’ duration. it had no effect, compared to placebo, on gastrointestinal pain or discomfort associated with nsaid use. see boxed warnings . misoprostol tablets should not be taken by pregnant women to reduce the risk of ulcers induced by nonsteroidal anti-inflammatory drugs (nsaids). misoprostol tablets should not be taken by anyone with a history of allergy to pr